Your email has been successfully added to our mailing list.

×
0 0 0 0 0 -0.000450788880540964 -0.0157813673929375 -0.00848985725018779
Stock impact report

Biogen boosts investment in neurology with $1 billion Ionis deal [Reuters]

Biogen Inc. (BIIB) 
Last biogen inc. earnings: 4/22 07:12 am Check Earnings Report
US:NASDAQ Investor Relations: biogen.com/en_us/investors.html
Company Research Source: Reuters
Biogen boosts investment in neurology with $1 billion Ionis deal | Reuters Reuters Staff 2 Min Read (Reuters) - U.S. drugmaker Biogen Inc rolled out part of its $37 billion investment warchest on Friday, signing a $1 billion deal that seeks to expand on the strength of an existing partnership with Ionis Pharmaceuticals Inc. The 10-year agreement, which gives Biogen the option to license and commercialize a range of neurological therapies, pushed shares in California-based Ionis up 9.5 percent to $50.20 before the bell. Ionis developed Spinraza, a treatment for rare disease spinal muscular atrophy that Biogen has licensed and sells. Analysts say it could replace multiple sclerosis treatment Tecfidera as Biogen’s biggest selling drug. The list price for Spinraza is $750,000 for the first year of therapy, dropping to about $375,000 a year after that. The deal, which comes ahead of Biogen’s first-quarter earnings report on Tuesday, includes a $625 million equity investment in Ionis and a Show less Read more
Impact Snapshot
Event Time:
BIIB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
BIIB alerts

from News Quantified
Opt-in for
BIIB alerts

from News Quantified